Pharma Journalist -

CEPI, the Coalition for Epidemic Preparedness Innovations, today announced a ninth worldwide collaboration to develop a COVID-19 vaccine. CEPI will invest an initial US$3.5 million in a…
Read More...

Takeda Pharmaceutical Company Limited announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for its investigational drug mobocertinib…
Read More...

Merck, known as MSD outside the United States and Canada, and the Institute for Systems Biology (ISB), announced a new research collaboration to investigate and define the molecular…
Read More...

Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and…
Read More...

JCR Pharmaceuticals Co., Ltd. announced that it has completed the previously announced acquisition of ArmaGen, Inc., a privately held US biopharmaceutical company headquartered in San…
Read More...

SMi reports: Workshop Overview for the Oligonucleotide Therapeutics and Delivery Conference, which will convene in London on 15th September 2020 one day before the conference taking…
Read More...

SMi Group reports: Key high profile industry experts to speak at 20th Annual Pain Therapeutics Conference on 11th and 12 May – Virtual Conference – Online Access Only. The highly…
Read More...

SMi Reports: Julian Dixon from Team Consulting Ltd is interviewed for the Injectable Drug Delivery conference SMi Group’s 3rd annual Injectable Drug Delivery is set to take place on…
Read More...

Takeda Pharmaceutical Company Limited announced that it has entered into an agreement to divest a portfolio of select non-core over-the-counter (OTC) and prescription pharmaceutical…
Read More...

Affinivax, Inc. a clinical stage biotechnology company with its novel MAPS technology platform for vaccines and immunotherapies, announced the completion of a $120 million Series B…
Read More...